Please login to the form below

Not currently logged in
Email:
Password:

Relay Therapeutics strengthens team

Don Bergstorm, Brian Adams and Tom Catinazzo join the biotech

Relay Therapeutics has appointed a new executive vice president, head of research and development in the form of Don Bergstorm.

Bergstorm joins the biotech from Mersana Therapeutics, where he led the advancement of two oncology products.

Prior to this, he was at Sanofi Oncology, where he held a global translational and experimental medicine position.

Relay Therapeutics has also appointed Brian Adams, who joins as its general counsel, bringing more than 15 years of legal and business management experience within the life science sector.

He has held roles for Keryx Biopharmaceutical, Algeta ASA and AVEO Oncology.

Last but not least, Tom Catinazzo has also joined Relay Therapeutics as its new vice president of finance.

Catinazzo brings over 12 years’ experience in the biotech field having worked at Aileron Therapeutics and Genzyme Corporation supporting both the renal and personalised genetic health division.

Sanjiv Patel, chief executive officer of Relay Therapeutics, said: “We welcome Don, Brian and Tom to the senior team at Relay Therapeutics.

“These seasoned leaders will help us to deliver transformational therapies using our novel integrated experimental and computational platform.

“We will continue to grow and add team members as our portfolio matures towards clinical development, and anticipate a move to our new headquarters in late 2018.”

23rd April 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PRMA Consulting Ltd

PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics